SEARCH:   Advanced

Erratum for Hochhaus et al., Blood 109 (6) 2303-2309. Blood, 1 September 2007, Vol. 110, No. 5, pp. 1438. This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Search for Related Content Social Bookmarking                   What's this?  Previous Article  |  Table of Contents  |  Next Article  ERRATUM Erratum for Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy In the article by Hochhaus et al entitled "Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy," which appeared in the March 15, 2007, issue of Blood (Volume 109:2303–2309), Table 2 contains an incorrect parenthetical percentage. The percentage rate of CHR for the imatinib-intolerant disease cohort at 8 months should be 97%. (The number of patients exhibiting CHR is accurate at 57.) CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Search for Related Content Social Bookmarking                   What's this?

	Copyright © 2007 by American Society of Hematology         Online ISSN: 1528-0020